Antibiotic Resistance in India: The Rising Cost and Mortality of Carbapenem-Resistant Infections

Gist A major study by the Indian Council of Medical Research ICMR has found that hospitalised patients infected with carbapenem-resistant bacteria face significantly higher mortality rates and treatment costs compared to those with drug-susceptible infections. This development highlights a critical vulnerability in India's healthcare system, as carbapenems are broad-spectrum reserve antibiotics used when frontline drugs fail. For civil services aspirants, this underscores the growing economic and public health burden of Antimicrobial Resistance AMR , shifting the policy focus from merely regulating antibiotic prescriptions to urgently upgrading infection prevention and control mechanisms in hospitals. Background Antimicrobial Resistance AMR : This is the acquired ability of bacteria to resist the effects of drugs meant to kill or suppress them. It is driven by genetic changes, inappropriate antibiotic use in healthcare and agriculture, and poor sanitation. Carbapenems: These are powerful, broad-spectrum antibiotics typically reserved by doctors as the last line of defence for severe, high-risk, or multi-drug-resistant infections. ICMR AMR Surveillance Network: A dedicated research mechanism that tracks bacterial resistance trends across Indian tertiary-care hospitals to inform national health policy. The Delta: Previously,…